Insider · CIK 0001926626
Lisa Hammond
Files at MDRX (Veradigm Inc.). First filing -, latest -.
In brief
Lisa Hammond files SEC Form 4 as officer at MDRX (Veradigm Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Lisa Hammond has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 5 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 2, 2025 | MDRX Veradigm Inc. | AGrant or award Common Stock | +58,140 | $4.30 | $250k | 174,175 | Jun 5, 2025 |
| May 25, 2025 | MDRX Veradigm Inc. | FTax withholding Common Stock | -1,526 | $4.40 | $6,714 | 116,035 | May 27, 2025 |
| May 9, 2025 | MDRX Veradigm Inc. | DDisposition to issuer Common Stock | -2,087 | $4.30 | $8,974 | 117,561 | May 12, 2025 |
| Apr 1, 2025 | MDRX Veradigm Inc. | FTax withholding Common Stock | -227 | $4.25 | $965 | 119,648 | Apr 2, 2025 |
| Feb 26, 2024 | MDRX Veradigm Inc. | AGrant or award Common Stock | +31,540 | $0.00 | $0 | 70,416 | Feb 28, 2024 |
Questions about Lisa Hammond
Answered from the filings on this page, as of the latest one.
Is Lisa Hammond buying or selling?
Lisa Hammond has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Lisa Hammond's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Lisa Hammond has 0.
Where does Lisa Hammond file Form 4?
Lisa Hammond has filed Form 4 at MDRX (Veradigm Inc.) as SVP & Chief HR Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.